COVID-19 in Patients with Multiple Sclerosis: Associations with Disease-Modifying Therapies.
CNS Drugs
; 35(3): 317-330, 2021 03.
Article
in En
| MEDLINE
| ID: mdl-33743151
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
COVID-19
/
Hospitalization
/
Immunosuppressive Agents
/
Multiple Sclerosis
Type of study:
Etiology_studies
/
Incidence_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Aged80
Country/Region as subject:
America do norte
Language:
En
Journal:
CNS Drugs
Journal subject:
FARMACOLOGIA
/
NEUROLOGIA
/
TERAPIA POR MEDICAMENTOS
Year:
2021
Type:
Article
Affiliation country:
United States